Gregory D Fink Selected Research

Salts

1/2021	Male and female high-fat diet-fed Dahl SS rats are largely protected from vascular dysfunctions: PVAT contributions reveal sex differences.
12/2019	Effects of high-fat diet on sympathetic neurotransmission in mesenteric arteries from Dahl salt-sensitive rat.
12/2019	Brain Prostaglandin D2 Increases Neurogenic Pressor Activity and Mean Arterial Pressure in Angiotensin II-Salt Hypertensive Rats.
11/2019	Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions.
1/2019	Renal Inflammation in DOCA-Salt Hypertension.
1/2018	Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.
1/2016	Possible role for brain prostanoid pathways in the development of angiotensin II-salt hypertension in rats.
1/2016	Serial Measurements of Splanchnic Vein Diameters in Rats Using High-Frequency Ultrasound.
7/2015	A mathematical model of salt-sensitive hypertension: the neurogenic hypothesis.
1/2015	A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory D Fink Research Topics

Disease

71	Hypertension (High Blood Pressure) 10/2023 - 02/2002
6	Hypotension (Low Blood Pressure) 12/2023 - 03/2008
6	Obesity 10/2022 - 05/2004
5	Ganglion Cysts (Ganglion) 12/2019 - 01/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2013
3	Inflammation (Inflammations) 10/2023 - 01/2018
2	Hypertrophy 01/2021 - 07/2007
2	Chronic Disease (Chronic Diseases) 12/2020 - 01/2016
2	Body Weight (Weight, Body) 01/2020 - 05/2007
2	Vascular Remodeling 07/2011 - 05/2007
2	Heart Valve Diseases (Valvular Heart Disease) 05/2007 - 05/2004
2	Familial Primary Pulmonary Hypertension 05/2007 - 05/2004
1	Renal Artery Obstruction (Renal Artery Stenosis) 10/2023
1	Renovascular Hypertension (Goldblatt Syndrome) 10/2023
1	Hyperemia 02/2023
1	Essential Hypertension 01/2021
1	Renal Hypertension 01/2019
1	Fibrosis (Cirrhosis) 08/2015
1	Weight Gain 01/2015
1	Hypothermia 07/2014
1	Necrosis 07/2014
1	Ischemia 07/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Tachycardia (Tachyarrhythmias) 04/2013
1	Septic Shock (Toxic Shock Syndrome) 03/2012
1	Brain Ischemia (Cerebral Ischemia) 07/2011
1	Stroke (Strokes) 07/2011

Drug/Important Bio-Agent (IBA)

48	SaltsIBA 01/2021 - 02/2002
28	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2019 - 02/2002
18	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2019 - 02/2002
17	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 02/2002
15	Angiotensin IIIBA 01/2016 - 02/2003
9	salicylhydroxamic acid (SHAM)IBA 01/2019 - 05/2007
9	Endothelin-1 (Endothelin 1)IBA 03/2008 - 04/2002
8	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2011 - 02/2003
7	Serotonin (5 Hydroxytryptamine)IBA 12/2023 - 10/2002
7	Superoxides (Superoxide)IBA 06/2011 - 02/2002
5	MineralocorticoidsIBA 11/2003 - 02/2003
5	ReninIBA 11/2003 - 02/2003
4	AdipokinesIBA 10/2022 - 06/2007
4	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 08/2015 - 02/2011
4	SodiumIBA 07/2015 - 02/2003
4	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2003 - 02/2003
3	serotonin 7 receptorIBA 12/2023 - 12/2020
3	ProstaglandinsIBA 12/2019 - 11/2013
3	Antihypertensive Agents (Antihypertensives)IBA 11/2019 - 02/2016
3	CytokinesIBA 01/2019 - 06/2007
3	Endothelins (Endothelin)IBA 03/2008 - 02/2003
2	Vasopressins (Vasopressin)IBA 10/2023 - 03/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2020 - 02/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020 - 06/2006
2	Hexamethonium (Hexamethonium Bromide)IBA 12/2019 - 02/2012
2	Ketoprofen (Orudis)FDA LinkGeneric 01/2016 - 11/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2016 - 11/2013
2	Allopurinol (Remid)FDA LinkGeneric 01/2013 - 12/2010
2	Xanthine OxidaseIBA 01/2013 - 12/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2010 - 01/2007
2	EnzymesIBA 12/2010 - 09/2003
2	FenfluramineIBA 05/2007 - 05/2004
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2003 - 02/2002
1	ArrestinIBA 12/2023
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2021
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2020
1	prostaglandin D2 receptorIBA 12/2019
1	Prostaglandin D2IBA 12/2019
1	BW A868CIBA 12/2019
1	Cyclooxygenase InhibitorsIBA 12/2019
1	KetorolacIBA 12/2019
1	LipocalinsIBA 12/2019
1	Therapeutic UsesIBA 02/2016
1	Dietary SodiumIBA 01/2015
1	benzamilIBA 02/2014
1	Sodium Channels (Sodium Channel)IBA 02/2014
1	Air Pollutants (Pollutants, Air)IBA 01/2014
1	OzoneIBA 01/2014
1	Particulate MatterIBA 01/2014
1	SC 560IBA 11/2013
1	nimesulide (Aulin)IBA 11/2013
1	Cyclooxygenase 1IBA 11/2013
1	Febuxostat FDA Link 01/2013
1	Uric Acid (Urate)IBA 01/2013
1	Doxycycline (Periostat)FDA LinkGeneric 07/2011
1	Metalloproteases (Metalloproteinases)IBA 07/2011
1	Matrix Metalloproteinases (MMPs)IBA 07/2011
1	Drinking WaterIBA 07/2011
1	ResveratrolIBA 06/2011
1	SympatholyticsIBA 06/2011
1	cyclonite (RDX)IBA 05/2011

Therapy/Procedure

10	Denervation 10/2023 - 09/2007
3	Therapeutics 10/2023 - 06/2011
2	Ganglionectomy 04/2013 - 09/2007
1	Surgical Instruments (Clip) 10/2023
1	Infusion Pumps (Infusion Pump) 12/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020
1	Aftercare (After-Treatment) 04/2013
1	Ligation 03/2012
1	Punctures 03/2012